Raltitrexed – 50 mg

Brand:
Cayman
CAS:
112887-68-0
Storage:
-20
UN-No:
De Minimis - 2811 / 6.1

Raltitrexed is an inhibitor of thymidylate synthase (Ki = 62 nM).{36978} It inhibits the growth of L1210 mouse lymphocytic leukemia cells in vitro (IC50 = 8 nM) as well as reduces thymidylate synthase activity and completely eliminates tumors in a mouse L1210:ICR ascitic tumor model when administered at a dose of 4 mg/kg, effects that can be reversed by administration of thymidine. It also reduces tumor growth and the number of metastases in an HCT116-luc mouse xenograft model.{36979} Formulations containing raltitrexed have been used in the treatment of advanced colorectal cancers.  

 

Available on backorder

SKU: 26079 - 50 mg Category:

Description

An inhibitor of thymidylate synthase (Ki = 62 nM); inhibits the growth of L1210 mouse lymphocytic leukemia cells in vitro (IC50 = 8 nM); reduces thymidylate synthase activity and completely eliminates tumors in a mouse L1210:ICR ascitic tumor model at 4 mg/kg; reduces tumor growth and the number of metastases in an HCT116-luc mouse xenograft model


Formal name: N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid

Synonyms:  ICI-D 1694|ZD 1694

Molecular weight: 458.5

CAS: 112887-68-0

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cancer|Cell Migration & Metastasis